Revenue has flattened, margins have structurally compressed to 40.9%, and challengers like On and Hoka are seizing wholesale shelf space. Yet Nike retains unmatched global scale and trades at a massive discount to historical multiples. The market is pricing a single question: is Nike’s innovation engine permanently stalled, or is it just between strides? Four analyst lenses, three scenarios, four time horizons.
Gray line = Nike's actual price decline into today ($80 mid-2025 → $40.00 52-week low → $40.90 now); colored paths = synthesized scenario midpoints forward, probability-weighted (base 50% · bull 25% · bear 25%). Log-linear, mid-year marks. Wall Street 12-month consensus ≈ $63.74 (range $23–$126).
Those probabilities are a judgment call — so make them yours. Drag to set how likely the bear and bull cases are (base takes the remainder); the blended target below, the dotted line on the chart, and the prob-weighted row of the scenario cards all update live.
The same fundamentals support wildly different conclusions depending on which framework you trust. Each lens below is a synthesized expert perspective with its own 12-month target.
The "Win Now" restructure is painful but necessary. Nike over-rotated into DTC and starved its retail partners, creating a vacuum for Hoka and On. With new leadership rebuilding wholesale relationships and the Alphafly/Pegasus innovation engine re-firing, the brand cachet will stabilize. The 50% multiple compression is a massive overreaction.
The growth days might be behind us, but you are buying a $46B cash machine at its 52-week low with a ~4.4% dividend yield. Inventories are finally clearing out, which will stop the gross margin bleeding. With an $18B buyback program and over $8B in cash, the downside is mathematically protected as long as revenue just holds flat.
This isn't a cyclical inventory issue; this is permanent brand dilution. Gen Z is abandoning the Jordan 1 and Dunk for terrace styles (Samba, Gazelle) and niche running brands (On, Hoka). Nike is forced to heavily promote to move stagnant inventory, permanently crushing the 46% peak gross margins. They are the IBM of sneakers now.
Nike outspends its closest competitors on sports marketing by an order of magnitude. No other brand commands the global athlete roster (LeBron, Mbappe, Alcaraz) or the supply chain leverage Nike possesses. The moat isn't just the shoe; it's the cultural ubiquity. Morningstar pegs intrinsic value in the $80s. Be greedy when others are fearful.
What the sell-side expects over the next year. Bars are sorted low to high; the dashed line is today's $40.90 — note the extremely wide dispersion reflecting the lack of consensus on the turnaround.
Sell-side 12-month targets — a selection of major firms; the full consensus mean is ≈ $63.74, about +56% above today. The dashed line marks today's $40.90: the stock has fallen so fast that even cautious "Hold" ratings imply upside from current levels. Firms, ratings, and targets illustrative of the current divergence.
Synthesized scenario midpoints (mid-year). Returns shown vs. today's $40.90. These are illustrative frameworks mapping out exactly how Nike's turnaround pace dictates the stock's terminal multiple.
Where the money goes. Revenue has flatlined, but Nike's sheer cash generation remains the ultimate safety net during the restructure.
Revenue (sky) has stalled and slightly contracted from its $51.3B peak in FY24 to an estimated $46.5B in FY26. Yet capital expenditures (clay) remain remarkably light, leaving billions in Free Cash Flow (olive) to fund the robust 4.4% dividend and buybacks. Debt (slate) remains highly manageable at ~$11.1B. This cash stability is the core of the value buyer's floor thesis.
The price targets aren't pulled from the air — each is an EPS estimate times an exit multiple. Here is the earnings recovery ladder required to hit the base-case $77 by 2031.
The painful reality of the reset: normalized EPS collapsed from $3.95 in FY24 to an estimated $1.50 low in FY26. The olive bars show the base-case recovery trajectory. If Nike can climb back to ~$3.60 per share by FY31, a normalized 21-22x multiple yields the ~$77 base-case 5-year target. The bear thesis fears the gray cliff is permanent.
Year-over-year revenue growth by segment (latest quarter). Read these against a stock sitting at its 52-week low.
The core business (olive) is undeniably struggling, largely driven by the messy unwind of the DTC-first strategy and fatigue in retro styles. However, the frontier segments (clay) — specific performance running tech, women's fitness, and emerging markets — are compounding. The bull case hinges on these bright spots outgrowing the legacy drag as new product cycles launch.
The entire valuation argument compresses into one disagreement: is Nike's innovation engine permanently stalled, or just between product cycles?
Where each headwind sits, not just how big it is. The hot upper-right corner — likely and high-impact — is what caused the current collapse.
Retailers give prime, permanent footprint to On, Hoka, and New Balance, refusing to return it to Nike once the DTC experiment ends.
The halo around the Jordan brand permanently fades with younger demographics shifting to terrace or gorpcore styles.
Nike is forced into heavy promotional discounting for multiple quarters to clear out legacy lifestyle inventory, crushing gross margins.
Geopolitical tensions trigger a sudden, widespread rejection of Western brands in Greater China, wiping out 15%+ of revenue.
The "Win Now" internal reorganization disrupts product development timelines even further.
A rival perfects localized, automated 3D-printed footwear at scale, neutering Nike's Asian supply chain advantage.
Hover the dotted terms in the metrics, or scan the desk's working definitions here.